RE:RE:Interesting AlwaysLong683 is being very polite and detailed here in regard to the drills/cores/assay results released so far in 2022.
What he really is asking here is NFG management blowing smoke up shareholders butts and being selective here in releasing only the "high grade" assays and not everything else that might have a negative effect on the stock price, since we have the $1B US valuation.
Let it be known that I'm on the record that the reassay issue is not going to change the numbers for the old assays enough to move the needle much one way or the other, just a few percent difference overall up or down in the grades already reported.